未登录First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial一线纳武利尤单抗联合铂类化疗和贝伐珠单抗治疗晚期非鳞非小细胞肺癌：TASUKI-52 III期随机试验3年随访
Lee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru .png)
分享.png)
收藏分享 收藏 分享 收藏 Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 TrialSolomon, Benjamin J.; Dagogo-Jack, Ibiayi; Lee, Se-Hoon; Boyer, Michael J.; Ramalingam, Suresh S.; Carcereny, Enric; Felip, Enriqueta; Han, Ji-Youn; Hida, Toyoaki; Hughes, Brett G. M.; Kim, Sang -We; Nishio, Makoto; Seto, Takashi; Okamoto, Tatsuro; Zhang, Xiaoxi; Martini, Jean -Francois; Wang, Erjian; De Beukelaer, Steven; Bauer, Todd M. 分享 收藏 A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangementHu, Wenbin; Zhao, Jiaming; Wang, Guoxia; Wang, Qihao; Deng, Mingming; Shen, Jie; Hofman, Paul; Urbanska, Edyta Maria; Santoni-Rugiu, Eric; Christopoulos, Petros; Ramirez, Robert A.; Hida, Toyoaki; Lu, Xiaoqing; He, Binjun 分享 收藏 分享 收藏 Diversity of TCR repertoire on peripheral CD8+PD-1+T-cell predicting the PFS of chemoradiotherapy followed by durvalumab maintenance in unresectable locally advanced NSCLC patientsShirasawa, Masayuki; Yoshida, Tatsuya; Takeyasu, Yuki; Matsutani, Takaji; Yagishita, Shigehiro; Kitano, Shigehisa; Kuroda, Hiroaki; Hida, Toyoaki; Kurata, Takayasu; Ohe, Yuichiro 分享 收藏 分享 收藏 International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease肺癌合并慢性阻塞性肺疾病诊治国际专家共识Zhou, Chengzhi; Qin, Yinyin; Zhao, Wei; Liang, Zhenyu; Li, Min; Liu, Dan; Bai, Li; Chen, Yahong; Chen, Yan; Cheng, Yuan; Chu, Tianqing; Chu, Qian; Deng, Haiyi; Dong, Yuchao; Fang, Wenfeng; Fu, Xiuhua; Gao, Beili; Han, Yiping; He, Yong; Hong, Qunying; Hu, Jie; Hu, Yi; Jiang, Liyan; Jin, Yang; Lan, Fen; Li, Qiang; Li, Shuben; Li, Wen; Li, Yaqing; Liang, Wenhua; Lin, Gen; Lin, Xinqing; Liu, Ming; Liu, Xiaofang; Liu, Xiaoju; Liu, Zhefeng; Lv, Tangfeng; Mu, Chuanyong; Ouyang, Ming; Qin, Jianwen; Ren, Shengxiang; Shi, Huanzhong; Shi, Minhua; Su, Chunxia; Su, Jin; Sun, Dejun; Sun, Yongchang; Tang, Huaping; Wang, Huijuan; Wang, Kai; Wang, Ke; Wang, Mengzhao; Wang, Qi; Wang, Wei; Wang, Xiaoping; Wang, Yuehong; Wang, Zhijie; Wang, Zirui; Wu, Lin; Wu, Di; Xie, Baosong; Xie, Min; Xie, Xiaohong; Xie, Zhanhong; Xu, Shufeng; Xu, Xiaoman; Yang, Xia; Yin, Yan; Yu, Zongyang; Zhang, Jian; Zhang, Jianqing; Zhang, Jing; Zhang, Xiaoju; Zhang, Yingying; Zhong, Diansheng; Zhou, Qing; Zhou, Xiangdong; Zhou, Yanbin; Zhu, Bo; Zhu, Zhengfei; Zou, Chenxi; Zhong, Nanshan; He, Jianxing; Bai, Chunxue; Hu, Chengping; Li, Weimin; Song, Yong; Zhou, Jianying; Han, Baohui; Varga, Janos; Barreiro, Esther; Park, Hye Yun; Petrella, Francesco; Saito, Yuichi; Goto, Taichiro; Igai, Hitoshi; Bravaccini, Sara; Zanoni, Michele; Solli, Piergiorgio; Watanabe, Satoshi; Fiorelli, Alfonso; Nakada, Takeo; Ichiki, Yoshinobu; Berardi, Rossana; Tsoukalas, Nikolaos; Girard, Nicolas; Rossi, Antonio; Passaro, Antonio; Hida, Toyoaki; Li, Shiyue; Chen, Liang'an; Chen, Rongchang 分享 收藏 Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR plus non-small-cell lung cancerNishio, Makoto; Atagi, Shinji; Goto, Koichi; Hosomi, Yukio; Seto, Takashi; Hida, Toyoaki; Nakagawa, Kazuhiko; Yoshioka, Hiroshige; Nogami, Naoyuki; Maemondo, Makoto; Nagase, Seisuke; Okamoto, Isamu; Yamamoto, Noboru; Igawa, Yuriko; Tajima, Kosei; Fukuoka, Masahiro; Yamamoto, Nobuyuki; Nishio, Kazuto 分享 收藏 Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinomaKatsuya, Yuki; Kitano, Shigehisa; Yamashita, Makiko; Ouchi, Mayu; Yagishita, Shigehiro; Hamada, Akinobu; Nakamura, Hiromi; Hosoda, Fumie; Shibata, Tatsuhiro; Motoi, Noriko; Nakayama, Takayuki; Seto, Takashi; Umemura, Shigeki; Hosomi, Yukio; Satouchi, Miyako; Nishio, Makoto; Kozuki, Toshiyuki; Hida, Toyoaki; Ohe, Yuichiro; Horinouchi, Hidehito 分享 收藏 分享 收藏 Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study纳扎替尼治疗初治EGFR突变非小细胞肺癌: 2期单臂开放标签研究的结果Tan, Daniel S. W.; Kim, Sang-We; Aix, Santiago Ponce; Sequist, Lecia, V; Smit, Egbert F.; Yang, James C. H.; Hida, Toyoaki; Toyozawa, Ryo; Felip, Enriqueta; Wolf, Juergen; Grohe, Christian; Leighl, Natasha B.; Riely, Gregory; Cui, Xiaoming; Zou, Mike; Ghebremariam, Samson; O'Sullivan-Djentuh, Leslie; Belli, Riccardo; Giovannini, Monica; Kim, Dong-Wan 分享 收藏 A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancerCao, Shuhui; Zhang, Yao; Zhou, Yan; Rong, Wenwen; Wang, Yue; Ling, Xuxinyi; Zhang, Lincheng; Li, Jingwen; Tomita, Yusuke; Watanabe, Satoshi; Nakada, Takeo; Seki, Nobuhiko; Hida, Toyoaki; Dermime, Said; Zhong, Runbo; Zhong, Hua 分享 收藏 分享 收藏 Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancerQiu, Bin; Cai, Kaican; Chen, Chun; Chen, Jun; Chen, Ke-Neng; Chen, Qi-Xun; Cheng, Chao; Dai, Tian-Yang; Fan, Junqiang; Fan, Zhaohui; Hu, Jian; Hu, Wei-Dong; Huang, Yun-Chao; Jiang, Ge-Ning; Jiang, Jie; Jiang, Tao; Jiao, Wen-Jie; Li, He-Cheng; Li, Qiang; Liao, Yong-De; Liu, Hong-Xu; Liu, Jun-Feng; Liu, Lunxu; Liu, Yang; Long, Hao; Luo, Qing-Quan; Ma, Hai-Tao; Mao, Nai-Quan; Pan, Xiao-Jie; Tan, Fengwei; Tan, Li-Jie; Tian, Hui; Wang, Dong; Wang, Wen-Xiang; Wei, Li; Wu, Nan; Wu, Qing-Chen; Xiang, Jiaqing; Xu, Shi-Dong; Yang, Lin; Zhang, Hao; Zhang, Lanjun; Zhang, Peng; Zhang, Yi; Zhang, Zhenfa; Zhu, Kunshou; Zhu, Yuming; Um, Sang-Won; Oh, In-Jae; Tomita, Yusuke; Watanabe, Satoshi; Nakada, Takeo; Seki, Nobuhiko; Hida, Toyoaki; Sasada, Shinji; Uchino, Junji; Sugimura, Haruhiko; Dermime, Said; Cappuzzo, Federico; Rizzo, Stefania; Cho, William Chi-Shing; Crucitti, Pierfilippo; Longo, Filippo; Lee, Kye Young; De Ruysscher, Dirk; Vanneste, Ben G. L.; Furqan, Muhammad; Sieren, Jessica C.; Yendamuri, Sai; Merrell, Kenneth W.; Molina, Julian R.; Metro, Giulio; Califano, Raffaele; Bongiolatti, Stefano; Provencio, Mariano; Hofman, Paul; Gao, Shugeng; He, Jie 分享 收藏 Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerSugawara, S.; Lee, J-S; Kang, J-H; Kim, H. R.; Inui, N.; Hida, T.; Lee, K. H.; Yoshida, T.; Tanaka, H.; Yang, C-T; Nishio, M.; Ohe, Y.; Tamura, T.; Yamamoto, N.; Yu, C-J; Akamatsu, H.; Namba, Y.; Sumiyoshi, N.; Nakagawa, K. 分享 收藏 A phase I dose-escalation study of mobocertinib (TAK-788), an oral tyrosine kinase inhibitor (TKI), in Japanese NSCLC patientsHida, T.; Nishino, M.; Yoh, K.; Asato, T.; Kitagawa, T.; Zhang, S.; Mehta, M.; Ohe, Y. 分享 收藏 Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients在预测肺癌患者对新辅助免疫疗法的病理反应方面，吸烟特征优于程序性死亡配体1表达Yang, Haitang; Ma, Wenyan; Sun, Beibei; Fan, Liwen; Xu, Ke; Hall, Sean R. R.; Al-Hurani, Mohammad Faisal; Schmid, Ralph A.; Peng, Ren-Wang; Hida, Toyoaki; Wang, Zhexin; Yao, Feng 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
